Amarin Corp. Plc (AMRN)
15.52
-0.30
(-1.90%)
USD |
NASDAQ |
Jan 12, 16:00
15.52
0.00 (0.00%)
After-Hours: 17:55
Amarin Research and Development Expense (Quarterly): 3.321M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Trinity Biotech Plc | 0.8134M |
| Jazz Pharmaceuticals Plc | 198.20M |
| DBV Technologies SA | 26.82M |
| Cellectis SA | 19.34M |
| Biodexa Pharmaceuticals Plc | -- |